- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03281928
Effect of Dietary Sodium and Potassium Citrate on Renal Mineral Handling
October 8, 2021 updated by: University of Chicago
This study intends to characterize the affect of sodium and potassium citrate in the diet on renal function.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
52
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Elaine Worcester
- Phone Number: 773-702-3630
- Email: eworcest@uchicago.edu
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60637
- Recruiting
- University of Chicago Medical Center
-
Contact:
- Elaine Worcester
- Phone Number: 773-702-7859
- Email: eworcest@medicine.bsd.uchicago.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 68 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- age 18 - 70, approximately equal numbers of men and women
- studied by endoscopy with complete papillary mapping and grading
- stone formers
Exclusion Criteria:
- Patients with primary renal diseases or renal impairment (eGFR < 90), or medical conditions such as diabetes, or systemic diseases or medications that alter calcium metabolism
- Patients with known bladder voiding problems
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Low Sodium plus Potassium Citrate
|
Sodium and potassium citrate levels will be altered in diet and renal mineral handling will be measured as compared to placebo.
|
Placebo Comparator: Low Sodium plus placebo
|
Sodium without Potassium Citrate
|
Experimental: High Sodium plus Potassium Citrate
|
Sodium and potassium citrate levels will be altered in diet and renal mineral handling will be measured as compared to placebo.
|
Placebo Comparator: High Sodium plus placebo
|
Sodium without Potassium Citrate
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Urine Calcium levels
Time Frame: 10 days
|
Amount of calcium in the urine will be measured
|
10 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 1, 2017
Primary Completion (Anticipated)
December 20, 2022
Study Completion (Anticipated)
December 20, 2022
Study Registration Dates
First Submitted
September 8, 2017
First Submitted That Met QC Criteria
September 8, 2017
First Posted (Actual)
September 13, 2017
Study Record Updates
Last Update Posted (Actual)
October 11, 2021
Last Update Submitted That Met QC Criteria
October 8, 2021
Last Verified
October 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB17-0992
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Kidney Stone
-
Washington University School of MedicineRecruiting
-
Société Internationale d'UrologieCompletedStone Ureter | Stone, Kidney | Stone;RenalUnited States, China, Korea, Republic of, Malaysia, Saudi Arabia, Greece, India, Indonesia, Iran, Islamic Republic of, Iraq, Kenya, Romania, South Africa, Taiwan, Turkey
-
Wake Forest University Health SciencesCogenix Medical CorporationWithdrawnKidney Stone | Renal Stone | Ureter StoneUnited States
-
Advance Shockwave Technology GmbHUnknownKidney StonesUnited States
-
Mansoura UniversityCompletedUrologic Diseases | Stone, Kidney | Stone, Urinary | ESWL | Radiolucent Calculus of Urinary Tract | DissolutionEgypt
-
University of British ColumbiaActive, not recruiting
-
Mansoura UniversityUnknownUrologic Diseases | Stones, Kidney | Stone, Urinary | Shock Wave LithotripsyEgypt
-
Selcuk UniversityThe Scientific and Technological Research Council of TurkeySuspendedKidney StonesTurkey
-
Mansoura UniversityCompleted
-
Alnylam PharmaceuticalsTerminatedRecurrent Calcium Oxalate Kidney Stone Disease | Elevated Urinary Oxalate LevelsUnited States, Italy, Spain, Belgium, Switzerland, United Kingdom
Clinical Trials on Sodium and Potassium Citrate
-
European Georges Pompidou HospitalInstitut National de la Santé Et de la Recherche Médicale, France; Sponsor...CompletedGlomerulonephritis | Cystinuria | Renal Lithiasis | Interstitial NephritisFrance
-
University of Texas Southwestern Medical CenterNot yet recruitingKidney StoneUnited States
-
University of Texas Southwestern Medical CenterCompleted
-
University of Texas Southwestern Medical CenterCompleted
-
University of California, IrvineNot yet recruitingUric Acid StonesUnited States
-
Ouiheng International Healthcare Co., LtdChulalongkorn University; Siriraj Hospital; ChaingMai University; Prince Songkla...Completed
-
University of DelawareRecruitingCardiovascular Risk FactorUnited States
-
University of DelawareCompleted
-
Advicenne PharmaTerminatedDistal Renal Tubular AcidosisUnited States, Canada
-
Cheng CaoRecruiting